The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The company shall process the change of name application with BSE Ltd. in due course
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Consolidated revenue from operations stood at Rs. 111.05 crore
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
Venus Remedies now has 29 active product approvals in Vietnam alone
Medico Remedies receives order worth US$ 1,781,000
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Subscribe To Our Newsletter & Stay Updated
